Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine

The significant public health problem of Hepatitis C virus (HCV) has been partially addressed with the advent of directly acting antiviral agents (DAAs). However, the development of an effective preventative vaccine would have a significant impact on HCV incidence and would represent a major advance...

Descripción completa

Detalles Bibliográficos
Autores principales: Christiansen, D., Earnest-Silveira, L., Chua, B., Meuleman, P., Boo, I., Grubor-Bauk, B., Jackson, D. C., Keck, Z. Y., Foung, S. K. H., Drummer, H. E., Gowans, E. J., Torresi, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915487/
https://www.ncbi.nlm.nih.gov/pubmed/29691437
http://dx.doi.org/10.1038/s41598-018-24762-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915487/
https://www.ncbi.nlm.nih.gov/pubmed/29691437
http://dx.doi.org/10.1038/s41598-018-24762-9

Ejemplares similares